Title
Enriching for tumor-reactive CD8 TIL using CD39/103 markers: Clinical implications
Document Type
Presentation
Publication Date
8-22-2022
Keywords
oregon; portland; chiles
Clinical Institute
Cancer
Department
Oncology
Recommended Citation
Weinberg, A, "Enriching for tumor-reactive CD8 TIL using CD39/103 markers: Clinical implications" (2022). Articles, Abstracts, and Reports. 6974.
https://digitalcommons.providence.org/publications/6974
Comments
Cell Therapy Durbility Response Summit; 2022 August 22; Boston, MA.